About Us

A catalyst for change

Our partnership is a catalyst for change, reimagining how we think about, innovate, and deliver health and wellness. Our goal is to set a new standard for how individuals and communities experience care across the state of Michigan and the nation.

Through a joint research enterprise, a premier cancer center, and a focus on academic medical and health education of the future, this partnership is working to fight the health disparities that plague our most vulnerable communities. We’re fueled by passion, curiosity, and a little bit of grit—tirelessly developing solutions, treatments and programs to make life collectively better.

Collaboration on big goals for lasting impact

We have ambitious goals and recognize that progress will take time. We’re committed to working with communities across the state to achieve meaningful, long-term change through this generational partnership. Because together, we can achieve more. Together, we can transform lives.

For more than a century, Henry Ford has embodied clinical research expertise, introducing the newest therapies for patients. MSU, an academic powerhouse for more than 150 years, has renowned strength in basic biomedical research. Together, we are bringing discoveries from bench to bedside. Our world-class research facility in Detroit, set to open in 2027, will further fuse basic and translational research, serving as an epicenter for innovation and discovery.

We are bringing together research and clinical applications to create a national and international destination for access to the most advanced cancer therapies and research. Partnership investments in cancer research total nearly $3 million in seed funding and integration grants designed to foster collaboration, with the aim to advance innovative clinical trials that improve patient outcomes.

We are working together to prepare the next generation of physicians and nurses to deliver patient-centered care. We have introduced a new campus of the MSU College of Human Medicine at Henry Ford Hospital in Detroit and expanded the MSU College of Nursing programs throughout the health system. We have also strengthened the long-standing partnership between Henry Ford Health and the MSU College of Osteopathic Medicine.

On January 1, 2026, we signed the Master Services Agreement (MSA). The MSA formalizes the integration of clinical services, including expanding services, improving access to quality care across Michigan, and implementing evidence-based best practices. The Henry Ford Medical Group, a nationally respected team of more than 2,800 providers and researchers, brings operational and financial expertise to support these goals. This is accomplished through shared leadership with MSU. MSU Health Care has adopted Henry Ford Health’s established systems to leverage economies of scale, access vendor networks, and tap into its expertise.

 

A deep commitment to the city of Detroit lies at the heart of this partnership. Henry Ford Health and MSU are leaders in advanced research, medical education, complex care, precision health, population health management, and value-based care. As closely aligned partners, we are positioned to make a greater impact than either could individually. We anticipate this partnership will result in:

  • Job creation for Detroit residents
  • Expanded access to health care in the city
  • Medical and nursing education and training opportunities for Detroit residents  
  • Increased diversity of future healthcare providers  
  • Establishing Detroit as a destination for the nation’s top practitioners, researchers and students  
  • Attracting industry partners and start-ups focused on health innovation

Our Partnership Leaders

We are uniting the brightest minds at Henry Ford Health and Michigan State University to transform research, education, and care into a bold new standard for health and wellness.

Meet Our Leaders
Leadership poses with Sparty.

Two powerhouses: stronger together 

By aligning our health sciences research, physician and nurse education, and clinical care, Henry Ford + MSU is poised to exponentially grow our ability to impact the health of those we serve.

Henry Ford Health

  • Footprint spanning 550 sites of care with 13 acute care hospitals and 4.9K licensed beds
  • 50K team members
  • One of the nation’s most respected physician group practices, with 3.5K+ physicians, scientists, and APPs
  • Flagship campus in Detroit is an 877-licensed bed tertiary quaternary care hospital with Level 1 Trauma
  • Magnet designation and plans underway for a $2.2 billion expansion
  • $13B in annual operating revenue
  • Insurance plan with 50K provider partners and 469K+ members 
About Henry Ford

Michigan State University

  • Presence in every county in the state of Michigan
  • 50K+ undergraduate and graduate students
  • Expansive alumni network totaling ~500K (306K living in Michigan)
  • No. 9 among public universities and No. 47 in U.S. News & World Report’s America’s Best Colleges 2025
  • Ranked in the top 50 research universities for 2024 by Washington Monthly
  • $992M+ in 2025 total research expenditures
  • 100+ research institutes and centers 
About MSU

A history of innovation and discovery 

For more than a century, Henry Ford Health has embodied clinical research expertise, pursuing the newest therapies for patients. Michigan State University, an academic powerhouse for more than 150 years, has a renowned strength in discovery research.

  • Among the nation’s original land grant universities and one of the top 100 research universities in the world, MSU’s discoveries across health sciences include the cancer fighting drug cisplatin, and plant sciences research to increase productivity, quality and nutrition of food crops being consumed around the globe.
  • In 2022, MSU introduced The Facility for Rare Isotope Beams, the world’s most powerful heavy-ion accelerator – enabling scientists to make discoveries about how the universe formed, while advancing innovation in medicine, nuclear security, environmental science and more.
  • A world-leader in medicine for over 100 years, Henry Ford’s ground-breaking work is far-reaching as well, and includes the drug commonly known as tPA for acute ischemic stroke, advances in treatment for severe sepsis and septic shock, and surgical innovations, including robotic surgery for prostate cancer and neuronavigation technologies for brain and spine surgery. Henry Ford also hosts one of the world’s largest brain tissue tumor banks.

We can’t wait to see what we will discover together.